Res Vestib Sci.  2013 Mar;12(1):27-30.

A Case of Bilateral Vestibular Hypofunction Following Oseltamivir Medication

Affiliations
  • 1Department of Otolaryngology, Gyeongsang National University School of Medicine, Jinju, Korea. skahn@gnu.ac.kr
  • 2Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju, Korea.

Abstract

The threat of pandemic influenza has focused attention and resources on virus surveillance, prevention, and containment. The World Health Organization has strongly recommended the use of the antiviral drug, Oseltamivir (Tamiflu(R)), to treat and prevent pandemic influenza infection. In recent years, there have been case reports of vestibulocochlear events during or after oseltamivir treatment, other countries. Oseltamivir is generally well-tolerated and its most frequent adverse effects include nausea and vomiting, diarrhea, and abdominal pain. Up to now, bilateral vestibular hypofunction after oseltamivir medication has not been reported. Herein, we report a very rare case of a 36-year-old female with bilateral vestibular hypofunction following oseltamivir medication.

Keyword

Vestibular function test; Oseltamivir; Drug toxicity

MeSH Terms

Abdominal Pain
Containment of Biohazards
Diarrhea
Drug Toxicity
Female
Humans
Influenza, Human
Nausea
Oseltamivir
Pandemics
Vestibular Function Tests
Viruses
Vomiting
World Health Organization
Oseltamivir
Full Text Links
  • RVS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr